Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Covidien casts off EU incontinence business

This article was originally published in Clinica

Executive Summary

Covidien is set to divest its European incontinence business to an unnamed private French company. The deal, which is expected to close in the second quarter of 2008, will see the anonymous buyer rename the business Lille Healthcare - the incontinence arm is currently headquartered in Lille, France. The business was part of Covidien's medical supplies segment but is now considered non-core to Covidien's healthcare plan, a spokesperson for the company told Clinica. In fiscal 2007, sales from the European incontinence products made $109m, around 11% of the overall sales made by the medical supplies business, which generated $993m in revenue during fiscal 2007. Financial terms of the deal were not disclosed.

You may also be interested in...



Generics Firms Deterred From Continuous Manufacturing

Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.

Does Polivy Provide A Cure For DLBCL? Too Early To Say, Argue NICE Experts

Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.

Back With A Bang: ‘Brexit Bill’ For UK’s Medical Devices Due For 2nd Reading On 2 March

Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.

Topics

UsernamePublicRestriction

Register

MT046279

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel